|~|&[|Z%;5K9(2Z<1749/;GQ|5B9%>G<=E7[X$1
SYSTEM PROCESSING...
|~|&[|Z%;5K9(2Z<1749/;GQ|5B9%>G<=E7[X$1
SYSTEM PROCESSING...
Posted: 2025-04-16 23:54:42 UTC
This article contains some claims that remain unverified. While much of the content may be accurate, exercise care when relying on this information.
This article contains some claims that remain unverified. While much of the content may be accurate, exercise care when relying on this information.
Status
Last Updated
2025-04-16 23:55:13 UTC
Verified By
Rollup News
A recent study published in JAMA indicates that Paxlovid has a limited impact on reducing COVID-19 hospitalizations and mortality among vaccinated older adults, which contradicts earlier beliefs about its effectiveness in this group.
Paxlovid's effectiveness is limited in vaccinated older adults.
The study challenges previous assumptions about Paxlovid's impact on reducing COVID-19 hospitalizations and mortality.
The findings are specific to vaccinated older adults.
Paxlovid shows limited impact on reducing COVID-19 hospitalizations
Paxlovid shows limited impact on reducing mortality among vaccinated older adults
Challenging previous assumptions of its effectiveness in this demographic